Brachytherapy is a form of radiotherapy used to treat many types of cancer. Internal radiotherapy, or seed therapy, is another name for it. In contrast to external beam radiotherapy, which distributes radiation from the outside of the body, brachytherapy functions by accurately targeting the cancerous tumor inside the body. Radioactive seeds are implanted within cancerous tissue and positioned in such a way that they kill the tumor most effectively. The method of using brachytherapy to target cancerous cells lowers the chance of any damages to healthy tissues and organs surrounding the tumors, therefore lowering the danger of adverse effects.
Get FREE Sample Report with Latest Covid19 Impact Analysis
Brachytherapy is used to treat cervix, prostate, skin, and breast cancers, as well as malignancies in other parts of the body such as the neck and head. Furthermore, it is usually used in cooperation with chemotherapy medicines to reduce the chance of recurrent cancer. Brachytherapy is classified into two types: permanent and temporary.
The increased incidences of prostate cancer is expected to drive the global brachytherapy market growth over the forecast period.
Growing number of prostate cancer cases is a huge factor in the global brachytherapy market growth during the forecast period.
According to the American Cancer Society, around 161,370 individuals were diagnosed with prostate cancer in 2017 and around 26,730 died as a result of prostate cancer in the U.S. In the U.S., prostate cancer is the third highest cause of death among males. Other factors driving the growth of the brachytherapy market are the increasing usage of high dose rate brachytherapy and the rising incidence of obesity. Furthermore, radiation therapy-related adverse effects such as tiredness, hair loss, nausea, and appetite loss are expected to hamper the global brachytherapy market growth over the forecast period.
Get PDF Brochure with Latest Insights
Market Taxonomy:
The global brachytherapy market is segmented on the basis of type, application, and geography
On the basis of dose type, the global brachytherapy market is segmented into:
- High Dose Rate Brachytherapy
- Low Dose Rate Brachytherapy
On the basis of application, the global brachytherapy market is segmented into:
- Prostate Cancer
- Breast Cancer
- Gynecological Cancer
- Others
The novel breast microseed therapy for breast cancer is expected to drive the brachytherapy market growth in North America over the forecast period.
The global brachytherapy market is divided into Europe, Latin America, North America, Asia Pacific, Africa, and the Middle East. Due to increasing acceptance of breast microseed therapy for breast cancer, North America is expected to account for the largest share in the global brachytherapy market. Breast microseed treatment with brachytherapy entails the accurate implantation of radioactive seeds in the breast that gradually release the specified dose safely over time. This is a novel therapy for early-stage breast cancer, which affects one in every eight women in North America.
For instance, according to the Centers for Disease Control and Prevention (CDC), around 2,141 males and 236,968 females were diagnosed with breast cancer in the U.S. in 2014. moreover, due to the introduction of the Esteya Machine for skin cancer treatment in 2016, Asia Pacific is projected to be a significant area in the global brachytherapy market. The treatment employs low-energy x-rays to target the cancerous area, with the potential to treat many lesions at the same time and a lower risk of scarring.
major players contributing to the global brachytherapy market are Cianna Medical, Theragenics Corporation, Argon Medical Devices, CIVCO Medical Solutions, Varian Medical Systems, Inc., IsoRay Medical, Sun Nuclear Corporation, iCAD Inc., Elekta, and Eckert & Ziegler BEBIG. major companies are concentrating on strategic mergers and acquisitions as well as the creation of new goods. For instance, IsoRay Inc. in 2016, announced the launch of a pilot study using the intraoperative placement of cesium-131 permanent interstitial brachytherapy in high-risk recurrent head and neck cancer.
Purchase This Premium Report To Access Full Information
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Brachytherapy Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Brachytherapy Industry Impact
Chapter 2 Global Brachytherapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Brachytherapy (Volume and Value) by Type
2.3 Global Brachytherapy (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Brachytherapy Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Brachytherapy Market Analysis
Chapter 6 East Asia Brachytherapy Market Analysis
Chapter 7 Europe Brachytherapy Market Analysis
Chapter 8 South Asia Brachytherapy Market Analysis
Chapter 9 Southeast Asia Brachytherapy Market Analysis
Chapter 10 Middle East Brachytherapy Market Analysis
Chapter 11 Africa Brachytherapy Market Analysis
Chapter 12 Oceania Brachytherapy Market Analysis
Chapter 13 South America Brachytherapy Market Analysis
Chapter 14 Company Profiles and Key Figures in Brachytherapy Business
Chapter 15 Global Brachytherapy Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837